Associate Director, Real-World Data and Analytics
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Director, Real-World Data and Analytics (RWDnA), to join our RWDnA team and help generate real-world evidence (RWE) that informs decisions across our portfolio. In this role, you will turn real-world data into data-driven insights, working with limited guidance to develop and implement analyses that address key research questions while collaborating with project teams, senior RWDnA colleagues, and external analytics partners.
Job description
Discover your role
- Deliver data-driven insights by analyzing real-world data to answer research questions
- Contribute to the development of RWE queries, protocols, and statistical analysis plans
- Execute hands-on programming and quality control of analytic code on internal RWD assets
- Evaluate and recommend appropriate RWD sources for specific research questions
- Communicate findings clearly to project teams and cross-functional partners
- Support abstracts, posters, manuscripts, and internal presentations
- Coordinate work with external analytics vendors and research partners
- Work independently, balance multiple priorities, and deliver high-quality results in a fast-paced environment
This role requires
- Doctoral degree in a quantitative discipline applying data science to healthcare data with 4+ years of hands-on programming experience, or a Master's degree in a related field with 6+ years
- Hands-on experience with RWD sources such as administrative claims, registries, and electronic healthcare records
- Advanced programming skills in SAS, R, and/or Python
- Proficiency in survival analysis, propensity score methods, and generalized linear models
- Excellent written and verbal communication skills, with the ability to collaborate in cross-functional teams
- Preferred: 3+ years of life science company or healthcare consulting experience; machine learning experience
Requirements
- Doctoral degree in a quantitative discipline applying data science to healthcare data with 4+ years of hands-on programming experience, or a Master's degree in a related field with 6+ years
- Hands-on experience with RWD sources such as administrative claims, registries, and electronic healthcare records
- Advanced programming skills in SAS, R, and/or Python
- Proficiency in survival analysis, propensity score methods, and generalized linear models
- Excellent written and verbal communication skills, with the ability to collaborate in cross-functional teams
- Preferred: 3+ years of life science company or healthcare consulting experience
- Preferred: machine learning experience
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.